Menu
Search
|

Menu

Close
X

CHF Solutions Inc CHFS.OQ (NASDAQ Stock Exchange Capital Market)

0.99 USD
-- (--)
As of Nov 15
chart
Previous Close 0.99
Open --
Volume --
3m Avg Volume 37,448
Today’s High --
Today’s Low --
52 Week High 24.45
52 Week Low 0.79
Shares Outstanding (mil) 12.52
Market Capitalization (mil) 7.48
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY18
3
FY17
4
FY16
1
FY15
0
EPS (USD)
FY18
-2.617
FY17
-34.901
FY16
-538.869
FY15
-881.301
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.64
Price to Sales (TTM)
vs sector
2.45
5.95
Price to Book (MRQ)
vs sector
0.78
4.89
Price to Cash Flow (TTM)
vs sector
--
22.90
Total Debt to Equity (MRQ)
vs sector
0.00
17.74
LT Debt to Equity (MRQ)
vs sector
0.00
13.15
Return on Investment (TTM)
vs sector
-130.18
14.22
Return on Equity (TTM)
vs sector
-154.86
15.99

EXECUTIVE LEADERSHIP

John Erb
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $385,833.00
Bonus: --
Claudia Drayton
Chief Financial Officer, Secretary, Since 2015
Salary: $260,000.00
Bonus: --
Vitaliy Epshteyn
Vice President of Operations and Engineering, Since 2018
Salary: --
Bonus: --
Gordon Weber
Vice President, General Counsel, Since 2017
Salary: --
Bonus: --
Carrie Powers
Vice President - Marketing, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

12988 Valley View Rd
EDEN PRAIRIE   MN   55344-3657

Phone: +1952.3454200

CHF Solutions, Inc., formerly Sunshine Heart, Inc., is a medical device company. The Company is focused on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System (Aquadex) is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy. Aquadex is also indicated for extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overloads who have failed diuretic therapy and require hospitalization.

SPONSORED STORIES